Adrian Sanborn

Adrian Sanborn is a seasoned biotech entrepreneur and scientist, currently serving as CEO and co-founder of a stealth startup focused on drug discovery since April 2024. With a rich background in bioscience research, Adrian previously held the position of Founding Scientist and Bioscience Lead at Atomic AI, where significant contributions were made in the discovery and validation of novel RNA targets for small molecule drugs. Educational credentials include a PhD in Computer Science from Stanford University, and participation in the selective Accel Innovation Scholar program at the Stanford Technology Ventures Program. Additionally, experience encompasses programming in bioinformatics and consulting roles at prestigious institutions such as Baylor College of Medicine, Broad Institute of MIT and Harvard, and Harvard University, along with an early engineering internship at Facebook.